NCT05102292 2023-08-21The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 MutationShanghai Henlius BiotechPhase 1/2 Unknown25 enrolled
NCT04574817 2020-10-05Study of HX008 for the Treatment of Anaplastic Thyroid Cancer (ATC)Taizhou Hanzhong biomedical co. LTDPhase 2 Unknown66 enrolled